Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy, Safety and Tolerability Study of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson's Disease

ClinicalTrials.gov ID: NCT02469090

Public ClinicalTrials.gov record NCT02469090. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 3:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Examine the Efficacy, Safety and Tolerability of APL-130277 in Levodopa Responsive Patients With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)

Study identification

NCT ID
NCT02469090
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
141 participants

Conditions and interventions

Interventions

  • APL-130277 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 17, 2015
Primary completion
Dec 10, 2017
Completion
Dec 10, 2017
Last update posted
Jul 29, 2020

2015 – 2017

United States locations

U.S. sites
32
U.S. states
18
U.S. cities
30
Facility City State ZIP Site status
University of Alabama, Birmingham Birmingham Alabama 35233
Muhammed Ali Parkinson and Movement Disorder CenterBarrow Neurological Phoenix Arizona
Movement Disorders Center of Arizona Scottsdale Arizona 85258
Mayo Clinic Arizona Scottsdale Arizona 85259
The Parkinson's and Movement Disorder Institute Fountain Valley California 92708
UC Irvine Health Gottschalk Medical Plaza Irvine California 92697
Keck Medical Center at USC Los Angeles California 90033
The Research Center of Southern California Oceanside California 92056
MedStar Georgetown University Hospital Washington D.C. District of Columbia 20007
Parkinsons Disease and Movement Disorders Center Boca Raton Florida 33486
University of Miami, Miller School of Medicine Miami Florida 33136
Parkinson's Disease Treatment Center of Southwest Florida Port Charlotte Florida 33980
USF Parkinson's Disease and Movement Disorder Center Tampa Florida 33613
Emory University Department of Neurology Atlanta Georgia 30329
Northwestern University Chicago Illinois 60611
Rush University Medical Center Chicago Illinois 60612
Central DuPage Hospital - Neurodegenerative Clinic - Movement Disorders Center Winfield Illinois 60190
Kansas University Medical Center - Department of Neurology Kansas City Kansas 66160
University of Kentucky Lexington Kentucky 40536
Johns Hopkins University Baltimore Maryland 21287
QUEST Research Institute Farmington Hills Michigan 48334
Northern Michigan Neurology Traverse City Michigan 49684
Henry Ford Hospital West Bloomfield Michigan 48322
Columbia University Medical Center - Neurological Institute, Movement Disorders New York New York 10032
Raleigh Neurology Associates, P.A. Raleigh North Carolina 27607
Wake Forest Baptist Health Winston-Salem North Carolina 27157
University of Cincinnati Cincinnati Ohio 45219
Cleveland Clinic Cleveland Ohio 44195
The Movement Disorder Clinic of Oklahoma Tulsa Oklahoma 74136
Jefferson University Hospital Philadelphia Philadelphia Pennsylvania 19107
University of Virginia, Adult Neurology Charlottesville Virginia 22903
Evergreen Health Kirkland Washington 98034

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02469090, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 29, 2020 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02469090 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →